Imeik Technology Development Co Ltd (SZSE:300896) Share Price

Company Profile

Business description
Imeik Technology Development is a leading Chinese medical aesthetics company, best known for its portfolio of hyaluronic acid-based solutions and gel injectable products. Founded in 2004 and headquartered in Beijing, the company has built its reputation on product innovation and a differentiated strategy, enabling it to rank first in China with a market share by value exceeding 20% in 2024. In 2025, Imeik acquired a controlling stake (approximately 60%) in South Korea’s Regen Biotech through a joint venture with an investment fund. Presently, almost all of Imeik’s revenue is derived domestically in China.
Contact
No. 92A, Jianguo Road
21st Floor, Tower C, Shimao Tower
Chaoyang District
Beijing100022
CHN
T: +86 1085809026
https://www.imeik.net
Sector
Healthcare
Stock type
Defensive
Industry
Medical Instruments & Supplies
Fiscal Year End
31 December 2026
Employees
1,223

Recommended

Rising inflation is the fly in the ointment.

Simonelle Mody | 08 January 2026

As we start the new year, let’s take a closer look at three compelling opportunities on the ASX

Tyger Fitzpatrick | 07 January 2026

Shares attractive due to near term profit margin increase and structural growth.

Johannes Faul, CFA | 07 January 2026

Index	Last price	Change	% Change
All Ordinaries	9,046.50	22.30	0.25%
CAC 40	8,224.53	9.39	-0.11%
DAX 40	25,061.92	60.34	-0.24%
Dow JONES (US)	48,898.71	97.37	-0.20%
FTSE 100	10,033.56	14.65	-0.15%
HKSE	26,149.31	309.64	-1.17%
NASDAQ	23,508.80	75.47	-0.32%
Nikkei 225	51,117.26	844.72	-1.63%
NZX 50 Index	13,716.86	1.84	0.01%
S&P 500	6,913.25	7.68	-0.11%
S&P/ASX 200	8,720.80	18.20	0.21%
SSE Composite Index	4,082.98	2.79	-0.07%